Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 57,700 shares at $89.61 ($5.0M) on 2024-02-05, disclosed to the SEC on 2024-02-05.
Scheduled sale ($5.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.44 | 9,761 | $844K | 16.7% |
| 2 | $86.44 | 9,761 | $844K | 16.7% |
| 3 | $87.55 | 12,167 | $1.1M | 21.1% |
| 4 | $87.55 | 12,167 | $1.1M | 21.1% |
| 5 | $88.63 | 6,422 | $569K | 11.3% |
| 6 | $88.63 | 6,422 |
| $569K |
| 11.3% |
| 7 | $89.61 | 1,000 | $90K | 1.8% |
| Total | $87.45 avg | 57,700 | $5.0M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |
| EW | SELL | 2023-12-13 | $3.6M | — | Filing → |